These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17093063)

  • 1. Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes.
    Stankovic AR; Fisher ND; Hollenberg NK
    J Am Soc Nephrol; 2006 Dec; 17(12):3293-9. PubMed ID: 17093063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus.
    Volkan-Salanci B; Dagdelen S; Alikasifoglu M; Erbas T; Hayran M; Erbas B
    J Renin Angiotensin Aldosterone Syst; 2009 Mar; 10(1):41-50. PubMed ID: 19286758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin release in response to Renin system blockade: activation of the Renin system in type 1 diabetes mellitus.
    Stevanovic RD; Price DA; Lansang MC; Fisher ND; Laffel LM; Hollenberg NK
    J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):78-83. PubMed ID: 16470486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus.
    Wilson DM; Luetscher JA
    N Engl J Med; 1990 Oct; 323(16):1101-6. PubMed ID: 2215578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term glycaemic control and the state of the renin system in type 1 diabetes mellitus.
    Stevanovic RD; Fisher ND; Lansang CM; Freeman KD; Hollenberg NK
    J Renin Angiotensin Aldosterone Syst; 2007 Jun; 8(2):85-92. PubMed ID: 17703435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The angiotensin II inhibition escape phenomenon in patients with type 2 diabetes and diabetic nephropathy].
    Shamkhlova MSh; Trubitsyna NP; Katsaia GV; Goncharov NP; Malysheva NM; Il'in AV; Nikankina LV; Koshel' LV; Shestakova MV
    Ter Arkh; 2008; 80(1):49-52. PubMed ID: 18326228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma prorenin as an index of prognostic evaluation in diabetes].
    Mossetti G; Salomone Megna A; Maddaloni D; Motti C; Gravina E
    Minerva Med; 1988 Nov; 79(11):931-6. PubMed ID: 3059233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of prostaglandins in the action of captopril in type II diabetic patients.
    Koev D; Zacharieva S; Andonova K
    Exp Clin Endocrinol; 1989 Apr; 93(1):11-8. PubMed ID: 2661245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin and beta-blockade: prorenin and aldosterone may explain the controversy.
    McKenna F; Davison AM
    Clin Nephrol; 1986 Mar; 25(3):149-54. PubMed ID: 2869848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal response to captopril reflects state of local renin system in healthy humans.
    Fisher ND; Price DA; Litchfield WR; Williams GH; Hollenberg NK
    Kidney Int; 1999 Aug; 56(2):635-41. PubMed ID: 10432403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the PPAR-gamma agonist rosiglitazone on renal haemodynamics and the renin-angiotensin system in diabetes.
    Lansang MC; Coletti C; Ahmed S; Gordon MS; Hollenberg NK
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):175-80. PubMed ID: 17094055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients.
    Patel TV; Williams GH; Fisher ND
    J Hypertens; 2008 Jul; 26(7):1353-9. PubMed ID: 18551010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between renin and prorenin in plasma from hypertensive patients and normal people: evidence for different renin:prorenin ratios.
    Leckie BJ; Morton JJ
    J Hum Hypertens; 1995 Jun; 9(6):493-6. PubMed ID: 7473533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of plasma immunoreactive active renin, inactive renin, plasma renin activity, and aldosterone to hemodialysis in patients with diabetic nephropathy.
    Sasamura H; Suzuki H; Takita T; Hayashi M; Ohno J; Shirai T; Saruta T
    Clin Nephrol; 1990 Jun; 33(6):288-92. PubMed ID: 2198118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blunted suppression of plasma renin activity in diabetes.
    Gordon MS; Price DA; Hollenberg NK
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):252-6. PubMed ID: 11881033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
    Kuiper JJ; Boomsma F; van Buren H; de Man R; Danser AH; van den Meiracker AH
    Eur J Clin Invest; 2008 Dec; 38(12):939-44. PubMed ID: 19021719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher levels of prorenin predict development of diabetic retinopathy in patients with type 2 diabetes.
    Yokota H; Nagaoka T; Tani T; Takahashi A; Sato E; Kato Y; Yoshida A
    J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):290-4. PubMed ID: 21330419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.